Welsh et al., Yoshihara et al. and Adib et al. reported that ANXA3 was highly expressed in ovarian serous carcinoma (P = 3.65E−5, fold change = 17.581; P = 2.50E−4, fold change = 2.121; P = 0.002; fold change = 5.145) [25, 26]. This evidence concerns the gene ANXA3 and ovarian serous carcinoma.